Tenet Healthcare (Tenet Healthcare) Other Operating Expense

: $5,369 Mil (TTM As of Dec. 2023)

View and export this data going back to 1976. Start your Free Trial

Tenet Healthcare's Other Operating Expense for the three months ended in Dec. 2023 was $1,410 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $5,369 Mil.

Tenet Healthcare's quarterly Other Operating Expense declined from Jun. 2023 ($1,330 Mil) to Sep. 2023 ($1,322 Mil) but then increased from Sep. 2023 ($1,322 Mil) to Dec. 2023 ($1,410 Mil).

Tenet Healthcare's annual Other Operating Expense declined from Dec. 2021 ($4,870 Mil) to Dec. 2022 ($4,645 Mil) but then increased from Dec. 2022 ($4,645 Mil) to Dec. 2023 ($5,369 Mil).

Tenet Healthcare Other Operating Expense Historical Data

The historical data trend for Tenet Healthcare's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenet Healthcare Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

5,021.00

4,100.00

4,870.00

4,645.00

5,369.00

Tenet Healthcare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															1,205.00	1,307.00	1,330.00	1,322.00	1,410.00

Tenet Healthcare Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,369 Mil.

Tenet Healthcare Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Tenet Healthcare's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenet Healthcare (Tenet Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tenet Healthcare Corp (NYSE:THC) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

THC:Mexico THC1:Germany

Address

14201 Dallas Parkway, Dallas, TX, USA, 75254

Website

https://www.tenethealth.com

Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of June 2023) and over 550 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Executives

Richard W Fisher	director
Roy Blunt	director	2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235
Paola M Arbour	officer: EVP, Chief Information Officer	14201 DALLAS PARKWAY, DALLAS TX 75254
Stephen H Rusckowski	director	C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Thomas W Arnst	officer: EVP, Chief Admin. Officer & GC	14201 DALLAS PARKWAY, DALLAS TX 75254
Tammy Romo	director	C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235
Daniel J Cancelmi	officer: Principal Accounting Officer	13737 NOEL ROAD, SUITE 100, DALLAS TX 75240
J Robert Kerrey	director	NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Richard J Mark	director	1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103
Ronald A Rittenmeyer	director	5400 LEGACY DRIVE, PLANO TX 75024
Lisa Y Foo	officer: EVP, Commercial Ops	14201 DALLAS PARKWAY, DALLAS TX 75254
Audrey T. Andrews	officer: SVP and General Counsel	1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202
Meghan Fitzgerald	director	C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Howard Hacker	officer: EVP, Chief Compliance Officer	14201 DALLAS PARKWAY, DALLAS TX 75254
Marie Quintana	officer: EVP, Marketing/Communications	14201 DALLAS PARKWAY, DALLAS TX 75254